{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:07Z","timestamp":1747207267510,"version":"3.40.5"},"reference-count":35,"publisher":"Bentham Science Publishers Ltd.","issue":"28","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>We explored circadian clock-related genes (CCRG) to establish a risk model and identify\nassociations with the tumor immune microenvironment in cutaneous melanoma (CM).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Circadian clock genes were downloaded from Circadian Gene Database. To explore CM-related\ncircadian clock genes, we combined multivariate cox regression associated with least absolute shrinkage and\nselection operator (LASSO) regression in the Cancer Genome Atlas (TCGA) and validated it in the GSE65904\ndataset. Time-dependent receiver operating characteristic curve (ROC) and Kaplan-Meier analysis were calculated\nto determine a CCRG risk score model. In addition, the overall survival nomograms of clinicopathological\nfactors and circadian clock-related gene signatures. Additionally, we evaluated the connection between\ncircadian clock-related genes with immune checkpoint inhibitors and immune cell infiltration.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Two circadian clock-related signatures were established. The risk model included SEMA4D (p&lt;0.001,\nHR: 0.709, 95% CI: 0.581 to 0.867) and SOD-2 (p=0.009, HR: 0.790, 95% CI: 0.663 to 0.944) in patients with\nTCGA melanoma. The risk model was based on two CCRGs enriched in base excision repair, glycosylphosphatidyl\n(GPI), and one carbon of the folate pathway. The overall survival was lower in the high-risk group. In addition,\nthe circadian-clock signature may be able to evaluate the immunotherapy response.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>We developed and validated a circadian signature to characterize the clinical significance and\ntumor microenvironment of cutaneous melanoma, revealing that circadian rhythms may impact cutaneous melanoma.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612828666220802114517","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T13:20:41Z","timestamp":1659446441000},"page":"2349-2361","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting\nSurvival for Cutaneous Melanoma"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-009X","authenticated-orcid":true,"given":"Ni","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"},{"name":"Department of\nDermatology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Guizhou, 563003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyue","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-0679","authenticated-orcid":true,"given":"Yueyue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwen","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing 210000,\nChina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0601-1507","authenticated-orcid":true,"given":"Yihe","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3105-8657","authenticated-orcid":true,"given":"Dan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"eaaz4530","DOI":"10.1126\/sciadv.aaz4530","volume":"6","author":"Aiello I.","year":"2020","unstructured":"Aiello I.; Fedele M.L.M.; Rom\u00e1n F.; Circadian disruption promotes tumor immune microenvironment remodeling favoring tumor cell proliferation. Sci Adv 2020,6(42),eaaz4530","journal-title":"Sci Adv"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0092-8674(02)01225-4","volume":"111","author":"Schibler U.","year":"2002","unstructured":"Schibler U.; Sassone C.P.; A web of circadian pacemakers. Cell 2002,111(7),919-922","journal-title":"Cell"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1038\/s41388-021-01778-6","volume":"40","author":"Battaglin F.","year":"2021","unstructured":"Battaglin F.; Chan P.; Pan Y.; Clocking cancer: The circadian clock as a target in cancer therapy. Oncogene 2021,40(18),3187-3200","journal-title":"Oncogene"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.arcmed.2019.10.008","volume":"50","author":"Bustamante-Montes L.P.","year":"2019","unstructured":"Bustamante-Montes L.P.; Flores M.B.; Hern\u00e1ndez M.A.; Night shift work and risk of breast cancer in women. Arch Med Res 2019,50(6),393-399","journal-title":"Arch Med Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/jbmr.2803","volume":"31","author":"Xu C.","year":"2016","unstructured":"Xu C.; Ochi H.; Fukuda T.; Circadian clock regulates bone resorption in mice. J Bone Miner Res 2016,31(7),1344-1355","journal-title":"J Bone Miner Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(02)00961-3","volume":"111","author":"Fu L.","year":"2002","unstructured":"Fu L.; Pelicano H.; Liu J.; Huang P.; Lee C.C.; The circadian gene period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002,111(1),41-50","journal-title":"Cell"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/ng.3677","volume":"48","author":"Riaz N.","year":"2016","unstructured":"Riaz N.; Havel J.J.; Kendall S.M.; Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. Nat Genet 2016,48(11),1327-1329","journal-title":"Nat Genet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3390\/ijms18112354","volume":"18","author":"Romano G.","year":"2017","unstructured":"Romano G.; Kwong L.; miRNAs, melanoma and microenvironment: An intricate network. Int J Mol Sci 2017,18(11),2354","journal-title":"Int J Mol Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","volume":"373","author":"Larkin J.","year":"2015","unstructured":"Larkin J.; Chiarion S.V.; Gonzalez R.; Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 2015,373(1),23-34","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fonc.2018.00185","volume":"8","author":"Assis L.V.M.","year":"2018","unstructured":"Assis L.V.M.; Kinker G.S.; Moraes M.N.; Markus R.P.; Fernandes P.A.; Castrucci A.M.L.; Expression of the circadian clock gene BMAL1 positively correlates with antitumor immunity and patient survival in metastatic melanoma. Front Oncol 2018,8,185","journal-title":"Front Oncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/948501","volume":"2015","author":"Vigneron N.","year":"2015","unstructured":"Vigneron N.; Human tumor antigens and cancer immunotherapy. BioMed Res Int 2015,2015,1-17","journal-title":"BioMed Res Int"},{"key":"ref=12","first-page":"D397","volume":"45","author":"Li S.","year":"2017","unstructured":"Li S.; Shui K.; Zhang Y.; CGDB: A database of circadian genes in eukaryotes. Nucleic Acids Res 2017,45(D1),D397-D403","journal-title":"Nucleic Acids Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","volume":"30","author":"Ahmed B.","year":"2020","unstructured":"Ahmed B.; Qadir M.I.; Ghafoor S.; Malignant melanoma: Skin cancer diagnosis, prevention, and treatment. Crit Rev Eukaryot Gene Expr 2020,30(4),291-297","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","volume":"5","author":"Sulli G.","year":"2019","unstructured":"Sulli G.; Lam M.T.Y.; Panda S.; Interplay between circadian clock and cancer: New frontiers for cancer treatment. Trends Cancer 2019,5(8),475-494","journal-title":"Trends Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"33376","DOI":"10.1074\/jbc.271.52.33376","volume":"271","author":"Furuyama T.","year":"1996","unstructured":"Furuyama T.; Inagaki S.; Kosugi A.; Identification of a novel transmembrane semaphorin expressed on lymphocytes. J Biol Chem 1996,271(52),33376-33381","journal-title":"J Biol Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"Alexandrov L.B.","year":"2013","unstructured":"Alexandrov L.B.; Nik Z.S.; Wedge D.C.; Signatures of mutational processes in human cancer. Nature 2013,500(7463),415-421","journal-title":"Nature"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/ijms18040873","volume":"18","author":"Shostak A.","year":"2017","unstructured":"Shostak A.; Circadian clock, cell division, and cancer: From molecules to organism. Int J Mol Sci 2017,18(4),873","journal-title":"Int J Mol Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2013.09.040","volume":"342","author":"Kelleher F.C.","year":"2014","unstructured":"Kelleher F.C.; Rao A.; Maguire A.; Circadian molecular clocks and cancer. Cancer Lett 2014,342(1),9-18","journal-title":"Cancer Lett"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrc2404","volume":"8","author":"Neufeld G.","year":"2008","unstructured":"Neufeld G.; Kessler O.; The semaphorins: Versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer 2008,8(8),632-645","journal-title":"Nat Rev Cancer"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.4049\/jimmunol.157.12.5262","volume":"157","author":"Herold C.","year":"1996","unstructured":"Herold C.; Elhabazi A.; Bismuth G.; Bensussan A.; Boumsell L.; CD100 is associated with CD45 at the surface of human T lymphocytes. Role in T cell homotypic adhesion. J Immunol 1996,157(12),5262-5268","journal-title":"J Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1074-7613(00)00062-5","volume":"13","author":"Kumanogoh A.","year":"2000","unstructured":"Kumanogoh A.; Watanabe C.; Lee I.; Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: A novel mechanism for regulating B cell signaling. Immunity 2000,13(5),621-631","journal-title":"Immunity"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1182\/blood.V95.3.965.003k39_965_972","volume":"95","author":"Billard C.","year":"2000","unstructured":"Billard C.; Delaire S.; Raffoux E.; Bensussan A.; Boumsell L.; Switch in the protein tyrosine phosphatase associated with human CD100 semaphorin at terminal B cell differentiation stage. Blood 2000,95(3),965-972","journal-title":"Blood"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/2326-6066.CIR-14-0171","volume":"3","author":"Evans E.E.","year":"2015","unstructured":"Evans E.E.; Jonason A.S.; Bussler H.; Antibody blockade of semaphorin 4D promotes immune infiltration into tumor and enhances response to other immunomodulatory therapies. Cancer Immunol Res 2015,3(6),689-701","journal-title":"Cancer Immunol Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e13298","DOI":"10.1097\/MD.0000000000013298","volume":"98","author":"Yang Y.","year":"2019","unstructured":"Yang Y.; Wang J.; Li H.; Liu L.; Yao M.; Xiao T.; Association between prognosis and SEMA4D\/Plexin-B1 expression in various malignancies. Medicine 2019,98(7),e13298","journal-title":"Medicine"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/08916934.2021.1925885","volume":"54","author":"Lu Q.","year":"2021","unstructured":"Lu Q.; Cai P.; Yu Y.; Liu Z.; Chen G.; Zeng Z.; Sema4D correlates with tumour immune infiltration and is a prognostic biomarker in bladder cancer, renal clear cell carcinoma, melanoma and thymoma. Autoimmunity 2021,54(5),294-302","journal-title":"Autoimmunity"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2012.04.031","volume":"53","author":"Liu Z.","year":"2012","unstructured":"Liu Z.; Li S.; Cai Y.; Manganese superoxide dismutase induces migration and invasion of tongue squamous cell carcinoma via H2O2 dependent Snail signaling. Free Radic Biol Med 2012,53(1),44-50","journal-title":"Free Radic Biol Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"25918","DOI":"10.1038\/srep25918","volume":"6","author":"Chang B.","year":"2016","unstructured":"Chang B.; Yang H.; Jiao Y.; SOD2 deregulation enhances migration, invasion and has poor prognosis in salivary adenoid cystic carcinoma. Sci Rep 2016,6(1),25918","journal-title":"Sci Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.1158\/0008-5472.CAN-14-3799","volume":"75","author":"Hemachandra L.P.M.P.","year":"2015","unstructured":"Hemachandra L.P.M.P.; Shin D.H.; Dier U.; Mitochondrial superoxide dismutase has a protumorigenic role in ovarian clear cell carcinoma. Cancer Res 2015,75(22),4973-4984","journal-title":"Cancer Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"14264","DOI":"10.1074\/jbc.M100199200","volume":"276","author":"Ranganathan A.C.","year":"2001","unstructured":"Ranganathan A.C.; Nelson K.K.; Rodriguez A.M.; Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2-dependent ERK1\/2 activation. J Biol Chem 2001,276(17),14264-14270","journal-title":"J Biol Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neo.2016.12.004","volume":"19","author":"Zhou H.","year":"2017","unstructured":"Zhou H.; Kann M.G.; Mallory E.K.; RETRACTED: Recruitment of Tiam1 to semaphorin 4D activates RAC and enhances proliferation, invasion, and metastasis in oral squamous cell carcinoma. Neoplasia 2017,19(2),65-74","journal-title":"Neoplasia"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"711145","DOI":"10.3389\/fimmu.2021.711145","volume":"12","author":"Yang Y.","year":"2021","unstructured":"Yang Y.; Li Y.; Qi R.; Zhang L.; Development and validation of a combined glycolysis and immune prognostic model for melanoma. Front Immunol 2021,12,711145","journal-title":"Front Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"639874","DOI":"10.3389\/fonc.2021.639874","volume":"11","author":"Tong X.","year":"2021","unstructured":"Tong X.; Qu X.; Wang M.; A four-gene-based prognostic model predicts overall survival in patients with cutaneous melanoma. Front Oncol 2021,11,639874","journal-title":"Front Oncol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"Schadendorf D.","year":"2018","unstructured":"Schadendorf D.; van Akkooi A.C.J.; Berking C.; Melanoma. Lancet 2018,392(10151),971-984","journal-title":"Lancet"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/CCO.0000000000000050","volume":"26","author":"Grimaldi A.M.","year":"2014","unstructured":"Grimaldi A.M.; Simeone E.; Ascierto P.A.; The role of MEK inhibitors in the treatment of metastatic melanoma. Curr Opin Oncol 2014,26(2),196-203","journal-title":"Curr Opin Oncol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1185\/03007995.2015.1021904","volume":"31","author":"Song X.","year":"2015","unstructured":"Song X.; Zhao Z.; Barber B.; Farr A.M.; Ivanov B.; Novich M.; Overall survival in patients with metastatic melanoma. Curr Med Res Opin 2015,31(5),987-991","journal-title":"Curr Med Res Opin"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220802114517","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207205\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220802114517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T16:59:59Z","timestamp":1691686799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207205\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":35,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612828666220802114517","relation":{},"ISSN":["1381-6128"],"issn-type":[{"type":"print","value":"1381-6128"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}